• It is unknown how regular exercise affects platelet function after menopause.
Essentials
• It is unknown how regular exercise affects platelet function after menopause.
• We studied the effect of 3-months of high-intensity exercise in pre-and postmenopausal women.
• Platelet sensitivity to the inhibitory effect of arterially infused prostacyclin was increased.
• Reduced basal platelet reactivity was seen in the premenopausal women only.
Summary. Background: The risk of atherothrombotic events increases after the menopause. Regular physical activity has been shown to reduce platelet reactivity in younger women, but it is unknown how regular exercise affects platelet function after the menopause. Objectives:
To examine the effects of regular aerobic exercise in late premenopausal and recent postmenopausal women by testing basal platelet reactivity and platelet sensitivity to prostacyclin and nitric oxide. Methods: Twenty-five sedentary, but healthy, late premenopausal and 24 matched recently postmenopausal women, mean (95% confidence interval) 49.1 (48.2-49.9) and 53.7 (52.5-55.0) years old, participated in an intervention study: 3-month high-intensity supervised aerobic spinning-cycle training (1 h, 9 3/week). Basal platelet reactivity was analyzed in platelet-rich plasma from venous blood as agonistinduced % aggregation. In a subgroup of 13 premenopausal and 14 postmenopausal women, platelet reactivity was tested ex vivo after femoral arterial infusion of prostacyclin, acetylcholine, a cyclooxygenase inhibitor, and after acute one-leg knee extensor exercise. Results: Basal platelet reactivity (%aggregation) to TRAP-6 (1 lM) was higher in the postmenopausal, 59% (50-68), than the premenopausal women, 45% (35-55). Exercise training reduced basal platelet reactivity to collagen (1 lg mL À1 ) in the premenopausal women only: from
Introduction
The menopause, with the consequent loss of estrogen, is associated with an accelerated rate of endothelial dysfunction and postmenopausal women have an increased risk of atherothrombotic events compared with premenopausal women [1] [2] [3] . Estrogen stimulates endothelial production of the platelet inhibitors nitric oxide [4] and prostacyclin [5] and has been shown to have an inhibitory effect on platelet aggregation in vitro [6, 7] . Thus, loss of estrogen following the menopause may result in increased platelet reactivity, but there is still debate over whether postmenopausal women have more reactive platelets than premenopausal women [8, 9] . Regular physical activity induces many of the same cardioprotective effects as estrogen on the cardiovascular system [10, 11] , including modulating platelet function [12, 13] . The effects of regular exercise on platelet function have been studied in young premenopausal women, and basal platelet reactivity [12] and platelet activation markers [13] were reduced by 2 months of regular aerobic exercise training. It is, however, unknown how regular physical activity influences platelet function after the menopause.
The aim of the current study was to evaluate platelet reactivity in healthy premenopausal and recently postmenopausal women of similar age, before and after a 3-month high-intensity aerobic exercise training intervention.
We hypothesized that postmenopausal women do have more reactive platelets compared with premenopausal women. In addition, we hypothesized that exercise training may compensate for the loss of estrogen during the menopause by normalizing platelet reactivity and enhancing platelet sensitivity towards endothelium-derived prostacyclin and nitric oxide.
Materials and methods
This cross-sectional, prospective, exercise intervention study was part of an interdisciplinary research initiative called the Copenhagen Women Study, looking into the effects of exercise training on women in the menopausal transition. More detailed information about the study design, recruitment of participants and training intervention are outlined in Mandrup et al. [14] . The protocol for this study was approved by the ethics committee of Copenhagen (H-1-2012-150). All subjects were informed of the risks and discomforts associated with the study and were recruited after providing their written informed consent to participate in the study in accordance with the Declaration of Helsinki. The study was registered at ClinicalTrials.gov (NCT02135575).
Subjects
The study included basal platelet reactivity testing of platelets (see experimental day 1) from 25 premenopausal and 24 postmenopausal women. A more in-depth analysis of platelet reactivity in response to various arterial infusions and acute exercise (see experimental day 2) was performed in a subgroup of 13 premenopausal women and 14 postmenopausal women. The women were recruited from the Copenhagen area via newspaper advertisements. The inclusion criteria were: premenopausal women aged 45-53 years still having normal and regular menstrual cycles and postmenopausal women aged 50-57 with amenorrhea for at least the past 2 years, who had BMI > 18.5 and < 30, and were sedentary (no regular physical activity for the last 2 years). Exclusion criteria included smoking, excessive alcohol intake, regular medication including hormone replacement therapy, or chronic disease. Menopausal status was verified by laboratory measurements of hypothalamic hormones, with premenopausal status defined as estrogen > 0. 20 .
Exercise training intervention
Experiments were performed before and after a 3-month supervised exercise training intervention where the subjects cycled on an ergometer for 1 h three times per week. Heart rate was monitored in all subjects during every spinning training session (FT2, Polar, Kempele, Finland)). The aim of each session was to provide interval training with intensities ranging from moderate to high intensity, with heart rates above 80% of maximal heart rate in all women for the majority of the training sessions [14] . Characterization of fitness level, by determination of pulmonary maximal oxygen uptake (VO 2 max, Oxycon Pro, Intramedic, Gentofte, Denmark), was assessed by an incremental bicycle ergometer exercise test (10-min warmup at 50W, followed by an incremental increase by 25W every minute until exhaustion) before and after the training intervention.
Preparation of optimul platelet aggregometry 96-well plates
This protocol was adapted from Chan et al. [15, 16] 24 h before the experimental days and to avoid non-steroidal anti-inflammatory drugs for at least 2 weeks prior to the experimental days. All the experimental days in the premenopausal women were strictly timed to occur within the mid-follicular phase of their ovarian cycle (7-15 days after their last period) in order to avoid possible confounding effects on platelet function by the different phases of the menstrual cycle as previously reported [17] .
Experimental day 1: determination of basal platelet reactivity and nitric oxide sensitivity
See Mandrup et al. [14] for a detailed methodological description of this experimental day. All participants had fasted overnight and had been resting in the supine position for over 30 min when blood was drawn from their antecubital vein. The primary outcome of this experimental day was to test if the postmenopausal women had higher basal reactivity than the premenopausal women and if this was affected by exercise training. Basal platelet reactivity was defined as agonist-induced ex vivo platelet aggregation in platelet-rich plasma (PRP) obtained from blood drawn at resting (basal) conditions. A secondary outcome of this experimental day was to examine platelet nitric oxide sensitivity in the women. Hence, PRP from a subgroup of n = 12 premenopausal and n = 12 postmenopausal women was preincubated in vitro for 1 min with the nitric oxide donor diethylamine NONOate (DEA/NONOate, D5431 Sigma, final concentrations 1-10 000 nM) before stimulation with collagen (4 lg mL À1 ) in the optimul aggregation assay.
Experimental day 2: determination of platelet reactivity after arterial infusions and acute exercise A full description of this experimental day can be found in Nyberg et al. [18, 19] . A subgroup of 13 premenopausal and 14 postmenopausal women participated in this experimental day. In short, catheters were inserted by a medical doctor under local anesthesia into the femoral artery (for infusions) and into the femoral vein (for blood sampling) of the experimental leg. After 20 min of rest, the infusion solutions were infused via a pump through the arterial catheter with the subject resting in a supine position. The infusion rates were based on the leg volume of the subject (calculated based on measurements of circumferences and partial lengths of the leg). The infusions were always performed in the same order and were separated by 30 min to avoid carryover effects. The ketorolac infusion was purposely performed as the last infusion, because of its long plasma half-life (4-6 h). According to the manufacturer of epoprostenol, the halflife in human plasma (based on inhibition of platelet aggregation) is 10.6 min in women and it has been reported that platelet reactivity returns towards baseline 10 min after discontinuation of an arterial acetylcholine infusion [20] . Hence the 30-min washout periods between the infusions used in our study protocol were sufficient to avoid carryover effects between the infusions. This was confirmed by a full return to baseline of blood flow and platelet reactivity after the 30-min washout period. , GlaxoSmithKline, Brondby, Denmark) was infused into the femoral artery for 2.5 min per dose and venous blood samples were collected at baseline and after 2.0 min of every infusion dose. Agonist-induced % platelet aggregation (platelet reactivity) testing was performed in PRP from these blood samples in order to test one of the primary outcomes of this study, namely if platelet sensitivity to prostacyclin is affected by menopausal status and/or by exercise training.
Epoprostenol infusion protocol
One-leg knee extensor acute exercise test The subject was transferred to the one-leg knee extensor (chair) ergometer and performed a 5-min one-leg knee extensor exercise at 10 Watt (W) and 20 W. Venous blood samples for platelet function testing were drawn at baseline and after the highest intensity bout (20 W) in order to test the effects of acute (localized) exercise at moderate intensity on platelet reactivity (a secondary outcome).
Acetylcholine infusion protocol Acetylcholine (Miochol-E, 10, 25 and 100 lg min À1 L leg volume À1 , Bausch & Lomb Inc., Bridgewater, NJ, USA) was infused into the femoral artery for 2.5 min per dose and blood samples were collected at baseline and after 2.0 min of every infusion dose. Venous blood samples for platelet function testing were collected at baseline and at the end of the highest infusion rate (100 lg min À1 L leg volume
À1
) in order to test another primary outcome of the study: investigating the effects of acetylcholine-stimulated endothelial release of nitric oxide and prostacyclin on platelet reactivity in both groups of women, before and after the training intervention.
Ketorolac plus acetylcholine infusion protocol Ketorolac (Toradol, 200 lg min À1 L leg volume À1 , Roche, Hvidovre, Denmark) was infused for 5 min before the acetylcholine protocol was repeated and kept constant until termination of the acetylcholine infusion. Venous blood samples for platelet function testing were collected after 4.5 min of ketorolac infusion and at the end of the highest acetylcholine infusion rate (100 lg min À1 L leg volume À1 ) in order to examine the contribution of platelet TXA 2 and endothelial prostacyclin and nitric oxide to platelet responses in each condition (another secondary outcome).
Optimul assay of platelet aggregation
On both experimental day 1 and 2, blood was collected into vacutainers (sodium citrate, 3.2% Greiner-bio-one 454332) and immediately centrifuged for 10 min (at 180 9 g, 20°C) in order to separate PRP from the red blood cells. The remaining blood was further centrifuged for 2 min (15 000 9 g, 20°C) to obtain platelet-poor plasma (PPP). Forty lL PRP or PPP was pipetted into the appropriate test and control wells of the agonist-coated optimul plate and placed on a shaker for 5 min (1200 rpm, 20°C, Eppendorf thermomixer EPP406, Hør-sholm, Denmark), read using a plate reader (Emax Precision Microplate Reader, Molecular Devices, Sunnyvale, CA, USA) and the light-absorbance by the PRP and PPP suspensions were measured at 595 nm. The test was typically completed within 30 min of blood collection and timings and pipetting order were kept the same before and after the training intervention to avoid bias.
Blood analysis
Whole blood samples were analyzed for estrogen (P-estradiol), follicle-stimulating hormone (FSH, P-follitropin) and luteinizing hormone (LH, P-lutropin) at the Department of Clinical Biochemistry at Rigshospitalet, using a competitive and a sandwich electrochemiluminescence immunoassay (Modular E-Module, Hoffmann-La Roche Ltd, Rotkreuz, Switzerland). Plasma concentrations of the prostacyclin breakdown product 6-keto prostaglandin F 1ɑ (6-keto PGF 1ɑ ) were measured using an immunoassay kit (EIA; 515211, Cayman Chemical Co).
Statistical analysis
The study size was based on power calculations of the primary outcome measure (platelet function and vascular function), using the standardized difference method [21] where the ɑ-level was set to 0.05 and the power level to 0.8, and on detecting a 20% difference in basal platelet reactivity after the training intervention, based on previous reports [12] and a 25% inhibitory effect size by the acetylcholine and epoprostenol infusions [20] . Data are The data from the n = 25 premenopausal and n = 24 postmenopausal women included in experimental day 1 (testing basal platelet reactivity before and after training) are highlighted in bold. Data confirming menopausal status of the n = 13 premenopausal and n = 14 postmenopausal women who participated in experimental day 2 (arterial infusions and acute exercise protocol) are highlighted in italics. *P < 0.05 between preand postmenopausal women. †P < 0.05 from before training.
reported as mean AE standard error of mean (SEM). Differences in subjects' characteristics (Table 1) were detected using a two-tailed t-test for paired or unpaired data. Statistical analysis was performed using GraphPad Prism5 and was analyzed using one-way or two-way ANOVA as appropriate, with Bonferroni multiple comparison post-test. The Kolmogorov-Smirnov test and the Shapiro-Wilk test of normality confirmed that the data were normally distributed. Missing data points led to the exclusion of subjects from the matched ANOVA analysis; final n-numbers are indicated in each figure legend.
Results

Subject characteristics
The premenopausal women were~4 years younger than the postmenopausal women ( Table 1 ). All the premenopausal women had regular menstrual bleeding and the menopausal status of all participants was verified by their hormonal levels ( Table 1 ). There was no difference in fitness level (VO 2 max, mL min À1 per kg) between the groups of women before the training intervention (Table 1) and exercise training increased VO 2 max similarly in the two groups (by 8.9 AE 1.5% in the premenopausal and by 8.8 AE1.6% in the postmenopausal women). Platelet count was within normal range (150-450 x10 9 /L), not different between the groups, and was not affected by exercise training (Table 1) . Mean platelet volume was also similar between the pre-and postmenopausal women, before and after the training intervention (approx. 9 fL, n = 16).
Basal platelet reactivity
The steepest part of the basal platelet reactivity aggregation response curves to TRAP-6 and U46619 were shifted to the left in the postmenopausal women, (Fig. 2C, D) and a smaller but similar left-hand shift was found in the aggregation response curves to epinephrine and ADP (Fig. 2B, E) . These left-hand shifted curves indicate that platelets from the postmenopausal women required fewer stimuli to aggregate and therefore had a higher reactivity to these agonists compared with platelets from the premenopausal women.
Exercise training had an inhibitory effect on collageninduced platelet aggregation in the premenopausal women only, indicating that exercise training lowered basal platelet reactivity to this agonist ( Fig. 2A) . No other alterations in basal platelet reactivity were observed following the training intervention.
Inhibitory effects on platelet reactivity by the in vivo infusion of prostacyclin Femoral arterial infusion of the prostacyclin analogue epoprostenol resulted in potent, dose-dependent inhibitory effects (right-hand shifts and reduction in maximal aggregation) on the collagen (Fig. 3) , TRAP-6 and ADP-induced platelet aggregation curves ( Figure S1 ). The platelet sensitivity to the inhibitory effects of the epoprostenol infusion was similar between the groups before the training intervention (Fig. 3C ). The epoprostenol infusion had a larger anti-aggregatory effect after the training intervention in both the premenopausal and the postmenopausal women (Fig. 3A, B) , which indicates that exercise training increased platelet sensitivity to the inhibitory effects of prostacyclin. This effect was greater in the postmenopausal women compared with the premenopausal women (Fig. 3D) .
Venous plasma levels of the prostacyclin breakdown product 6-keto PGF 1ɑ were not different between the groups of women at baseline and increased~20-fold after the highest epoprostenol dose (Fig. 5A, B) . These levels did not change after the training intervention.
Platelet reactivity after acute one-leg knee extensor exercise
The acute one-leg knee extensor exercise (at 20 W moderate intensity) had an inhibitory effect on platelet aggregation that was enhanced after the training intervention in both the premenopausal and the postmenopausal women (Fig. 4 and Figure S2 ). This inhibitory effect was more pronounced in the premenopausal women (Fig. 4A, C and Figure S2 ). The 6-keto PGF 1ɑ plasma levels were reduced after the exercise in both groups of women to a similar extent, both before and after the training intervention, and the levels did not differ between the groups of women (Fig. 5C,  D) . Additionally, the acute exercise did not affect platelet count, before or after the training intervention in either group (Table S1 ).
Platelet reactivity after arterial acetylcholine and ketorolac infusions
The arterial acetylcholine infusion had an inhibitory effect on platelet aggregation in both groups of women (Fig. 6A, B) After the exercise intervention, the inhibitory effect of the acetylcholine infusion had increased in the premenopausal women only (Fig. 6A and Figure S3 ).
Arterial infusion of the non-selective cyclooxygenase inhibitor ketorolac led to a right-hand shift of the aggregation curves and a reduction in maximal aggregation to a similar degree as acetylcholine alone ( Figure S4 ). The coinfusion of acetylcholine and ketorolac further reduced platelet aggregation (Fig. 6C) . The inhibitory effect of this co-infusion was enhanced in the premenopausal women after the training intervention ( Fig. 6C and Figure S4 ).
The acetylcholine infusion led to a~20-fold increase in venous plasma 6-keto PGF 1a levels [18] , which were similar in both groups and unaffected by the training intervention. Basal platelet reactivity (agonist-induced % platelet aggregation concentration response curves) to five concentrations of (A) collagen, (B) epinephrine, (C) thrombin receptor activating peptide (TRAP-6), (D) U46619 (a TXA 2 mimetic) and (E) adenosine diphosphate (ADP) in platelet-rich plasma from venous blood drawn at rest from the antecubital vein of previously sedentary (n = 22-25) pre-and postmenopausal women, before and after a 3-month aerobic exercise training intervention. *P < 0.05, between groups; ¤P < 0.05, from before training; ɸP < 0.05, overall difference between the curves between the groups.
In vitro testing of platelet nitric oxide sensitivity
The two highest concentrations of DEA/NONOate inhibited collagen-induced platelet aggregation to a similar degree in both groups of women. There was no difference in platelet sensitivity to inhibition by DEA/NONOate after the training intervention (Fig. 7) .
Discussion
The primary outcomes of the current study were: (i) sedentary, recently postmenopausal women had more reactive platelets compared with matched late premenopausal women of similar age; (ii) a period of high-intensity aerobic exercise training reduced basal platelet reactivity in the premenopausal but not the postmenopausal women; (iii) the training intervention enhanced platelet sensitivity to the inhibitory, anti-aggregatory effects of the arterial prostacyclin infusion and acute one-leg knee extensor exercise in both groups of women.
Findings from previous studies that have examined platelet reactivity in pre-and postmenopausal women have been inconsistent [8, 9] , and a main confounding factor may have been the sizeable age differences (10 to 15-year age variance) between the pre-and postmenopausal women studied. The current study was designed to minimize the age difference between the pre-and postmenopausal women, leading to a mean age difference of only around 4 years. In agreement with our initial hypothesis, we found that platelets from postmenopausal women were more reactive to aggregate when challenged with several different platelet agonists, compared with platelets from premenopausal women. Our findings may, together with other risk factors such as elevated blood pressure, endothelial dysfunction and raised cholesterol, explain the increased incidence of atherothrombotic events in postmenopausal women.
The underlying mechanism behind the hyperactive platelets in the postmenopausal women could potentially be a result of their diminished levels of estrogen following the menopause. Both megakaryocytes and circulating human platelets have been reported to contain the estrogen receptor b [22, 23] and 17b-estradiol has been shown to have inhibitory effects on platelet aggregation in vitro [6, 7] . Hence, circulating estrogen in the premenopausal women may have a direct inhibitory effect on platelet reactivity that is missing in the postmenopausal women. Additionally, estrogen may have a genomic effect on megakaryocytes to produce platelets with a less reactive phenotype, and consequently when the hormonal milieu is altered after the menopause, megakaryocytes may be reprogrammed to produce platelets that are more reactive. Alternatively, because estrogen has been shown to stimulate endothelial production of nitric oxide [4] and prostacyclin [5] , the hyperactive platelets in the postmenopausal women may also be a result of endothelial dysfunction, resulting in impaired endothelial regulation of platelet reactivity. Our group has previously reported that the postmenopausal women in the current study did have a reduced vasodilatory response to the prostacyclin and acetylcholine infusion compared with the premenopausal women, indicating that their vascular endothelial function was indeed impaired [18] . Their vasodilatory response (vascular function) did, however, improve with the exercise training, whereas their basal platelet reactivity remained unaltered (still higher than the premenopausal women). This indicates that endothelial dysfunction was not the reason behind the hyperactive platelets in the postmenopausal women. Our finding that basal platelet reactivity was reduced by the exercise training in the premenopausal women only, was in contrast to what we hypothesized, and indicates that this particular adaptation to aerobic exercise training is estrogen dependent. A role for estrogen is further supported by previous findings on the effects of aerobic exercise training in young premenopausal women [12] . It is noteworthy that this inhibitory effect on basal platelet reactivity by the exercise training in the premenopausal women was collagen specific because platelet responses towards the other agonists were not affected. Accordingly, Wu et al. reported that 17b-estradiol inhibited collagen-induced platelet aggregation more potently than other agonists [6] . Future studies should focus on investigating platelet-collagen interactions to see if, for instance, platelet collagen receptors (i.e. glycoprotein VI) are affected by exercise training and estrogen levels.
In the current study, through a unique approach of in vivo arterial infusion of the prostacyclin analogue (epoprostenol), we found that platelets from both the preand postmenopausal women were significantly more inhibited by prostacyclin after the training intervention.
Because plasma levels of the prostacyclin hydrolysis breakdown product ) during the infusion were the same before and after the intervention, this confirms the consistency of the protocol and that exercise training does not alter prostacyclin metabolism/clearance. Hence, the enhanced inhibitory effect of the prostacyclin infusion after the training intervention can be explained by the exercise training increasing the sensitivity of platelets to prostacyclin, which confirms our initial hypothesis. In accordance with these results, a study from Sinzinger et al. observed increased platelet sensitivity to prostacyclin (added in vitro) after a 1-year jogging intervention in younger men and women [24] . Dix et al. also reported a higher platelet prostacyclin sensitivity in marathon runners compared with non-runners and they reported that this was because of a greater activity of the membranebound adenylate cyclase enzyme in their platelets, which generates inhibitory cyclic AMP [25] . In the current study, using a unique human in vivo model, we have been able to replicate these findings both in a more physiological setting and in older pre-and postmenopausal women, indicating that this important platelet adaptation to exercise training is preserved with older age and after the menopause. Contrary to what we hypothesized, there was, however, no difference in nitric oxide sensitivity between the groups of women, before or after the training intervention, suggesting that neither the menopausal transition nor exercise training affects platelet nitric oxide sensitivity.
The effects of acute exercise on platelet function appear to be intensity dependent because moderate exercise has been shown to suppress platelet reactivity, whereas acute strenuous exercise has been shown to temporarily increase platelet reactivity [26, 27] . The acute one-leg dynamic knee extensor exercise test used in this study was conducted at moderate intensity and the benefit of using this model is that it allows for assessment of a localized effect of a single active muscle group [28] with blood sampling obtained from the femoral vein draining the exercising leg. By use of this model, we report for the first time that a bout of one-leg knee extensor exercise had an inhibitory effect on platelet aggregation and that this effect was significantly enhanced after the training intervention period in both the pre-and the postmenopausal women. One possible explanation for the greater inhibitory effect of the acute exercise after training could be an enhanced nitric oxide bioavailability as endothelial nitric oxide synthase (eNOS) protein levels were higher in thigh skeletal muscle samples from both the pre-and postmenopausal women, after the training intervention [19] . In addition, the greater platelet sensitivity to prostacyclin observed in the infusion experiments could have contributed to a larger inhibitory effect of exercise-induced prostacyclin release after the training period.
Study limitations
One potential limitation of this study is that the platelet reactivity assay used in this study requires that the blood samples are centrifuged to obtain PRP and thus there is a time delay (~10 min) after blood collection. This could have affected the magnitude of the inhibitory effects that were detected in the platelet responses following the acute exercise and arterial infusion protocols. The investigator performing this assay was not blinded to the identity of the blood samples, but because this is a quantitative test of platelet aggregation, the potential for bias was minimal. Another limitation is the lack of a non-training control group. We decided not to include one because our primary objective was to evaluate differences in training response in the pre-and postmenopausal women. Furthermore, we did not choose a crossover design for the study because it would be difficult to control for carryover effects from the physical activity intervention.
One more limitation with our study was that our study populations were probably healthier than the general population (considering they had normal weight and were normotensive [14, 18] ), and hence the generalizability of the current results would need to be confirmed in less healthy (for instance overweight and hypertensive) preand postmenopausal women in larger-scale studies, such as the ongoing platelet function testing in the Framingham study.
Conclusion
In conclusion, the present study demonstrates that basal platelet reactivity is increased in women within only a few years after the menopause, which may contribute to the rapid increased risk of cardiovascular events in postmenopausal women. Moreover, the novel finding that regular exercise training can increase platelet sensitivity to prostacyclin in both pre-and postmenopausal women highlights a previously unknown mechanism behind the cardioprotective effects of regular exercise. . Inhibitory effects of the arterial prostacyclin infusion on platelet reactivity ex vivo. Fig. S2 . Inhibitory effects on platelet reactivity after acute one-leg knee extensor exercise. Fig. S3 . Inhibitory effects on platelet reactivity after arterial acetylcholine infusion. Fig. S4 . Inhibitory effects on platelet reactivity after arterial infusion of acetylcholine plus ketorolac. Table S1 . Platelet count at baseline and after 20W acute one-leg knee extensor exercise.
